BioTech Medics, Inc.
BMCS · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $3,339 | $7,265 | $1,659 | $13,760 |
| - Cash | $0 | $0 | $0 | -$1 |
| + Debt | $2 | $27 | $0 | $0 |
| Enterprise Value | $3,341 | $7,291 | $1,659 | $13,761 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$3 | $186 | -$115 | -$86 |
| % Margin | – | – | – | – |
| Net Income | -$3 | -$6 | -$115 | -$323 |
| % Margin | – | – | – | – |
| EPS Diluted | 0 | 0 | -0.001 | -0.002 |
| % Growth | – | 100% | 62.5% | – |
| Operating Cash Flow | – | -$27 | -$17 | -$182 |
| Capital Expenditures | – | $0 | $0 | -$2 |
| Free Cash Flow | – | -$27 | -$17 | -$184 |